Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03367689
Title A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)
Acronym NOBROLA
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital del Mar Barcelona Spain Details
Onkologikoa Donostia Spain Details
Institut Català d' Oncologia L'Hospitalet (ICO) L'Hospitalet De Llobregat Spain Details
Hospital Ramón y Cajal Madrid Spain Details
Hospital Arnau de Vilanova de Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field